Subscribe To
ARKAY / Arkema: Anticipate A 15% EBITDA Increase In 2024
ARKAY News
By Zacks Investment Research
September 29, 2023
Arkema (ARKAY) to Expand DMDS Production Capacity in Texas
Arkema (ARKAY) is investing Euro 130 million to expand its DMDS production capacity in Texas to meet the surging demand for renewable fuels. more_horizontal
By Zacks Investment Research
September 28, 2023
Arkema (ARKAY) Expands Organic Peroxide Production in China
Arkema (ARKAY) is investing Euro 50 million to boost organic peroxide production in China for renewable energy markets. more_horizontal
By Seeking Alpha
September 4, 2023
Arkema: Anticipate A 15% EBITDA Increase In 2024
Arkema will remain profitable and free cash flowing this year, but all eyes are on 2024. The company's Q2 2023 revenue decreased by 23% compared to Q2 more_horizontal
By Zacks Investment Research
July 5, 2023
Arkema (ARKAY) Boosts Polymers Range With Majority Stake in PIAM
Arkema (ARKAY) acquires a controlling stake in PI Advanced Materials, broadening its high-performance polymer range and transforming it into a pure sp more_horizontal
By Seeking Alpha
June 10, 2023
Arkema: Entering Oversold Territory
Arkema remains in the midst of a cyclical downturn. The stock has not been spared, underperforming by a wide margin over the last year. But with the v more_horizontal
By Seeking Alpha
May 6, 2023
Arkema S.A. (ARKAF) Q1 2023 Earnings Call Transcript
Arkema S.A. (OTCPK:ARKAF) Q1 2023 Earnings Conference Call May 5, 2023 5:30 AM ET Company Participants Thierry Le Henaff - Chairman & CEO Marie-Jose D more_horizontal
By Seeking Alpha
March 18, 2023
Arkema: Diversified End-Markets With A Balanced Geo Footprint
Lower exposure to EU (thanks also to M&A) and a solid balance sheet to navigate a weaker 2023. Arkema increased its DPS by 13%. more_horizontal
By Zacks Investment Research
March 8, 2023
ARKAY vs. AKZOY: Which Stock Is the Better Value Option?
ARKAY vs. AKZOY: Which Stock Is the Better Value Option? more_horizontal